Nomura Holdings Inc Intercept Pharmaceuticals, Inc. Transaction History

Nomura Holdings Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 18, 2022	SELL	$13.37 - $17.79 $169,678 - $225,772	-12,691 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.28 - $19.53 $181,227 - $247,855	12,691 New	12,691 $207,000
Q1 2021 May 17, 2021	SELL	$19.33 - $37.75 $444,589 - $868,250	-23,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$24.48 - $42.47 $342,720 - $594,580	14,000 Added 155.56%	23,000 $568,000
Q3 2020 Nov 12, 2020	SELL	$39.09 - $53.44 $351,810 - $480,960	-9,000 Reduced 50.0%	9,000 $373,000
Q2 2020 Aug 14, 2020	BUY	$46.7 - $92.04 $70,050 - $138,060	1,500 Added 9.09%	18,000 $862,000
Q2 2019 Aug 14, 2019	BUY	$77.77 - $120.68 $1.07 Million - $1.65 Million	13,700 Added 489.29%	16,500 $1.31 Million
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $255,654 - $335,973	2,784 Added 17400.0%	2,800 $312,000
Q4 2018 Feb 14, 2019	SELL	$85.79 - $126.46 $158,625 - $233,824	-1,849 Reduced 99.14%	16 $2,000
Q3 2018 Nov 14, 2018	BUY	$88.49 - $127.55 $165,033 - $237,880	1,865 New	1,865 $236,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.